BARCLAYS PLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 157 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,188
+157.3%
339,846
+137.5%
0.01%
+175.0%
Q2 2023$6,680
+126.1%
143,078
+85.3%
0.00%
+300.0%
Q1 2023$2,954
-47.9%
77,224
-25.4%
0.00%
-66.7%
Q4 2022$5,674
-85.8%
103,552
+8616.5%
0.00%
Q3 2022$40,000
-64.9%
1,188
-90.2%
0.00%
Q2 2022$114,000
+6.5%
12,078
+58.7%
0.00%
Q1 2022$107,000
-92.9%
7,610
-89.3%
0.00%
Q4 2021$1,498,000
+375.6%
70,860
+403.7%
0.00%
Q3 2021$315,000
+131.6%
14,068
+156.9%
0.00%
Q2 2021$136,000
-63.1%
5,476
-57.1%
0.00%
Q1 2021$369,000
+141.2%
12,757
+114.8%
0.00%
Q4 2020$153,000
-39.3%
5,938
-27.3%
0.00%
Q3 2020$252,000
-41.9%
8,169
-53.0%
0.00%
Q2 2020$434,000
+635.6%
17,399
+525.4%
0.00%
Q1 2020$59,000
-47.3%
2,782
-44.6%
0.00%
Q4 2019$112,000
+83.6%
5,018
+88.9%
0.00%
Q3 2019$61,0002,6570.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders